UPDATE ON THALASSEMIA AND HEMOGLOBINOPATHIES. Guest Editor: R. Origa

Posted on 2018-09-25

 

β-THALASSEMIA DISTRIBUTION IN THE OLD WORLD: A HISTORICAL STANDPOINT OF AN ANCIENT DISEASE

Vincenzo De Sanctis

 DOI https://doi.org/10.4084/mjhid.2017.018   Pages e2017018   PDF     HTML

  

PREGNANCY IN THALASSEMIA 

 Raffaella Origa, Federica Comitini  DOI https://doi.org/10.4084/mjhid.2019.019       Pages e2019019         PDF  HTML  

 

DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA

 Ali Taher

 DOI https://doi.org/10.4084/mjhid.2018.066     Pages e2018066   PDF HTML

 

  REVIEW AND RECOMMENDATIONS ON MANAGEMENT OF ADULT FEMALE THALASSEMIA PATIEΝTS WITH HYPOGONADISM BASED ON LITERATURE REVIEW AND EXPERIENCE OF ICET-A NETWORK SPECIALISTS  

Vincenzo DeSanctis  

DOI https://doi.org/10.4084/mjhid.2017.001      Pages e2017001  PDF     HTML    

 

   THYROID DISORDERS IN HOMOZYGOUS β-THALASSEMIA: CURRENT KNOWLEDGE, EMERGING ISSUES AND OPEN PROBLEMS  

Vincenzo De Sanctis

 DOI https://doi.org/10.4084/mjhid.2019.029        Pages e2019029        PDFHTML    

 

 IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION: TIME TO CHANGE THE PARADIGM. 

 Federica Pilo  

DOI https://doi.org/10.4084/mjhid.2019.030        Pages e2019030        PDF     HTML   

 

HYDROXYCARBAMINE: FROM AN OLD DRUG USED IN MALIGNANT HEMOPATHIES TO A CURRENT STANDARD IN SICKLE CELL DISEASE  

Giovanna Cannas, Solene Poutrel, Xavier Thomas  

DOI https://doi.org/10.4084/mjhid.2017.015             Pages e2017015   PDF  HTML  

 

NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE

 Alessandro Matte, Filippo Mazzi, Enrica Federti, Oliviero Olivieri, Lucia De Franceschi

 DOI https://doi.org/10.4084/mjhid.2019.002     PDF HTML 

 

CURING HEMOGLOBINOPATHIES: CHALLENGES AND ADVANCES OF CONVENTIONAL AND NEW GENE THERAPY APPROACHES.  Irene Motta, Valentina Ghiaccio, Andrea Cosentino, Laura Breda  DOI https://doi.org/10.4084/mjhid.2019.067           Pages e2019067   PDF    HTML